These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3893105

  • 1. Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants.
    Gordon RD, Iwatsuki S, Shaw BW, Starzl TE.
    Am J Kidney Dis; 1985 Jun; 5(6):307-12. PubMed ID: 3893105
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
    Martin DC, Tertzakian G, Ruzics E.
    J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
    [Abstract] [Full Text] [Related]

  • 3. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 May; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 4. Kidney retransplantation in the cyclosporine era.
    Stratta RJ, Oh CS, Sollinger HW, Pirsch JD, Kalayoglu M, Belzer FO.
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [Abstract] [Full Text] [Related]

  • 5. Renal function and somatic growth in pediatric cadaveric renal transplantation with cyclosporine-prednisone immunosuppression.
    Ellis D, Avner ED, Rosenthal JT, Taylor RJ, Young LW, Palumbi MA, Hakala TR.
    Am J Dis Child; 1985 Nov; 139(11):1161-7. PubMed ID: 3904407
    [Abstract] [Full Text] [Related]

  • 6. Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
    Shaffer D, Hammer SM, Monaco AP.
    Am J Surg; 1987 Apr; 153(4):381-6. PubMed ID: 3105340
    [Abstract] [Full Text] [Related]

  • 7. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract] [Full Text] [Related]

  • 8. Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age.
    Pirsch JD, Stratta RJ, Armbrust MJ, D'Alessandro AM, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplantation; 1989 Feb; 47(2):259-61. PubMed ID: 2645709
    [Abstract] [Full Text] [Related]

  • 9. Use of cyclosporine in pediatric renal transplant recipients.
    Conley SB, Flechner SM, Rose G, Van Buren CT, Brewer E, Kahan BD.
    J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
    [Abstract] [Full Text] [Related]

  • 10. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
    Barry JM, Shively N, Hubert B, Hefty T, Norman DJ, Bennett WM.
    Transplantation; 1988 Feb; 45(2):346-8. PubMed ID: 3278427
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
    Canadian Multicentre Transplant Study Group.
    N Engl J Med; 1986 May 08; 314(19):1219-25. PubMed ID: 2871486
    [Abstract] [Full Text] [Related]

  • 12. Cadaveric renal transplantation under cyclosporine-steroid therapy.
    Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW, Starzl TE.
    Surg Gynecol Obstet; 1983 Oct 08; 157(4):309-15. PubMed ID: 6353643
    [Abstract] [Full Text] [Related]

  • 13. Does cyclosporine influence the results of cadaver retransplantation?
    Flechner SM, Lorber MI, Kerman RH, Van Buren CT, Wideman C, Kahan BD.
    Hum Immunol; 1985 Nov 08; 14(3):305-13. PubMed ID: 3902748
    [Abstract] [Full Text] [Related]

  • 14. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun 08; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine in renal transplantation: a single institutional experience.
    Ferguson RM, Sommer BG.
    Am J Kidney Dis; 1985 Jun 08; 5(6):296-306. PubMed ID: 3925761
    [Abstract] [Full Text] [Related]

  • 16. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA, Serota AI.
    Transplantation; 1988 Feb 08; 45(2):320-3. PubMed ID: 3278422
    [Abstract] [Full Text] [Related]

  • 17. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS, Samhan M, John P, al-Adnani MS, Abouna GM.
    Transplant Proc; 1989 Feb 08; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD, Mickey R, Flechner SM, Lorber MI, Wideman CA, Kerman RH, Terasaki P, Van Buren CT.
    Transplant Proc; 1987 Feb 08; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract] [Full Text] [Related]

  • 19. Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A.
    Rosenthal JT, Hakala TR, Starzl T, Iwatsuki S, Shaw BW.
    J Urol; 1984 Jan 08; 131(1):17-8. PubMed ID: 6361283
    [Abstract] [Full Text] [Related]

  • 20. Kidney transplantation in the cyclosporine era.
    Halasz NA, Gamboa EA, Ward DM, Steiner RW, Bronsther OL.
    Arch Surg; 1987 Sep 08; 122(9):1001-4. PubMed ID: 3304197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.